BrightFocus Foundation is a premier source of global research funding to defeat Alzheimer’s, macular degeneration, and glaucoma. The organization is the only nonprofit dedicated to finding cures for diseases of mind and sight and has supported nearly 2,000 projects since inception, a more than $275 million investment. BrightFocus shares the latest research findings and expert information to empower families impacted by these diseases. Please visit Science.BrightFocus.org for more information on current grants and how to apply for future funding.
We are delighted to announce the following companies/organisations/institutes as Sponsors of the XXV Biennial ISER Meeting 2023.
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries worldwide. We are promoting the Focus Area Approach designed to identify opportunities for continuously creating new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Particularly, in Primary Focus Blindness and Regeneration, we are committed to developing transformative therapies to restore sight and free patients from the fear of deteriorating vision. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients.
The University of Sydney
The Save Sight Institute (SSI) is home to many of Australia’s leading ophthalmologists, researchers, and scientists. SSI is one of six Flagship Centres in the Faculty of Medicine and Health at the University of Sydney. Established in 1985 and based at the Sydney Eye Hospital, SSI has grown to be one of the top two ophthalmic research institutes in Australia. SSI is internationally recognised as a centre of innovative research into clinical ophthalmology and vision science and is a centre of excellence for clinical research, learning and teaching.
Ophthalmology at the University of Sydney is ranked sixth in the world by the Centre for World University Rankings (CWUR, 2019). The centre currently has more than 70 substantive staff, 176 clinical affiliates and 14 higher degree research students. Research at the SSI encompasses four broad domains: basic vision science, research translation, clinical trials, and disease outcomes. Our cutting-edge laboratory research lays the foundation for our complementary work in clinical trials, implementation, and ongoing patient monitoring through our global outcome registry projects.
If you have further questions, please don’t hesitate to contact Industry Services at the official ISER Meeting Secretariat:
2023 ISER Meeting Secretariat
c/o K.I.T. Group GmbH
We look forward to hearing from you!